Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response

Convalescent plasma (CP) has been trialed as a therapy for SARS-CoV-2 symptoms, but its heterogenous nature precludes uniform outcomes. Here the authors perform deep profiling of CP, as well as plasma of CP recipients before and after transfer, to find CP-mediated, spike/nucleocapsid-focused modulat...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Jonathan D. Herman, Chuangqi Wang, Carolin Loos, Hyunah Yoon, Johanna Rivera, M. Eugenia Dieterle, Denise Haslwanter, Rohit K. Jangra, Robert H. Bortz, Katharine J. Bar, Boris Julg, Kartik Chandran, Douglas Lauffenburger, Liise-anne Pirofski, Galit Alter
Format: article
Langue:EN
Publié: Nature Portfolio 2021
Sujets:
Q
Accès en ligne:https://doaj.org/article/5214fb7ba9d240e5bff4799c7e668657
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!